AKT1 and viral pneumonia: In addition, our results showed that XCH treatment reduced the phosphorylation of PI3K, AKT, and NF-κB p65 in lung, indicating that XCH could inhibit the activation PI3K/AKT/NF-κB signaling pathway in viral pneumonia model mice.